Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2012
08/14/2012CA2513527C Pyrimidine derivatives for the prevention of hiv infection
08/14/2012CA2511509C Benzoazolylpiperazine derivatives having vr1 antagonist activity
08/14/2012CA2509687C Process for the production of 2'-branched nucleosides
08/14/2012CA2498233C Clear ophthalmic solution comprising latanoprost as active ingredient
08/14/2012CA2497845C Liquid aerosol formulations and aerosol generating devices and methods for generating aerosols
08/14/2012CA2494568C Patches containing tulobuterol
08/14/2012CA2489705C Use of amide derivative of ge 2270 factor a3 for the treatment of acne
08/14/2012CA2472021C Substituted methylene amide derivatives as modulators of protein tyrosine phosphatases (ptps)
08/14/2012CA2469028C Pharmaceutical composition in the form of gel or solution based on dihydrotestosterone, preparation method and uses thereof
08/14/2012CA2468302C Compounds for treatment of inflammation, diabetes and related disorders
08/14/2012CA2457485C Combination motif immune stimulatory oligonucleotides with improved activity
08/14/2012CA2452075C Sustained release delivery system
08/14/2012CA2451187C Zero-order prolonged release coaxial implants
08/14/2012CA2446622C Isostearic acid salts as permeation enhancers
08/14/2012CA2436326C Combination therapy using receptor tyrosine kinase inhibitors and angiogenesis inhibitors
08/14/2012CA2404679C Adenine binding g-protein coupled receptors
08/14/2012CA2386362C Nutritional or therapeutic compositions comprising lcpufa for the treatment of anandamide-mediated ailments
08/14/2012CA2386069C Indolyl-3-glyoxylic acid derivatives as antitumor agents
08/14/2012CA2383509C Use of nicotine or derivatives thereof in a medicine for treating neurological diseases, in particular parkinson disease
08/14/2012CA2381095C Method for treating insulin resistance through hepatic nitric oxide
08/14/2012CA2218166C Methods of inducing immune tolerance using immunotoxins
08/10/2012CA2731454A1 A herbal and vitamin c composition used for treating inflammation and the mainenance of good health
08/09/2012WO2012106722A2 Treatment of bacterial infections
08/09/2012WO2012106714A1 Implantable device for controlled release of low solubility drug
08/09/2012WO2012106702A2 Treatment of leukemia
08/09/2012WO2012106654A1 Methods for treating brain injury
08/09/2012WO2012106584A2 Pitavastatin salts
08/09/2012WO2012106569A1 Alpha-ketoheterocycles and methods of making and using
08/09/2012WO2012106551A1 Bakuchiol compositions for treatment of post inflammatory hyperpigmentation
08/09/2012WO2012106540A1 Methods of using alk inhibitors
08/09/2012WO2012106537A1 Compositions and methods for treatment of glaucoma
08/09/2012WO2012106534A2 Hiv integrase inhibitors
08/09/2012WO2012106524A2 Diagnosis and treatment of the prodromal schizophrenic state
08/09/2012WO2012106522A2 Bicyclic and tricyclic pyrimidine tyrosine kinase inhibitors with antitubulin activity and methods of treating a patient
08/09/2012WO2012106509A1 Sirtuin modulators as virus production modulators
08/09/2012WO2012106508A1 Method of treating keloids or hypertrophic scars using antisense compounds targeting connective tissue growth factor (ctgf)
08/09/2012WO2012106499A1 Pyrrolopyrazine-spirocyclic piperidine amides as modulators of ion channels
08/09/2012WO2012106472A1 Naphthyridine derivatives as inhibitors of hypoxia inducible factor (hif) hydroxylase
08/09/2012WO2012106469A2 Methods for treating infections by targeting microbial h2s-producing enzymes
08/09/2012WO2012106461A2 Combination therapy for treatment of cancer
08/09/2012WO2012106448A1 Heterocyclic compounds as janus kinase inhibitors
08/09/2012WO2012106426A1 Isolated compounds from turmeric oil and methods of use
08/09/2012WO2012106404A2 Diagnosis and treatment of neurological disorders through vipr2 and vpac2r
08/09/2012WO2012106393A2 Withanolide isolated from physalis longifolia and analogs and methods of use thereof
08/09/2012WO2012106382A1 Aerosol pirfenidone and pyridone analog compounds and uses thereof
08/09/2012WO2012106379A1 Sensitization of cancer cells to treatment
08/09/2012WO2012106343A2 Hdac inhibitors and therapeutic methods using the same
08/09/2012WO2012106303A1 Pharmaceutical formulations including an amine compound
08/09/2012WO2012106302A1 Combination
08/09/2012WO2012106299A1 Pharmaceutical compositions of cytidine analogs and methods of use thereof
08/09/2012WO2012106287A2 Methods of treating acute kidney injury with retinoc acid
08/09/2012WO2012106190A1 C-17 and c-3 modified triterpenoids with hiv maturation inhibitory activity
08/09/2012WO2012106189A1 Methods of making hiv attachment inhibitor prodrug compound and intermediates
08/09/2012WO2012106188A1 C-28 amines of c-3 modified betulinic acid derivatives as hiv maturation inhibitors
08/09/2012WO2012106118A2 Method of making ophthalmic devices and components thereof from hydrophobic acrylic (ha) polymers with reduced or eliminated glistenings
08/09/2012WO2012106058A2 Animal treatments
08/09/2012WO2012105990A1 Bakuchiol compositions for treatment of post inflammatory hyperpigmentation
08/09/2012WO2012105982A1 Skin renewal enhancer
08/09/2012WO2012105887A1 Active principle for mitigating undesired medical conditions
08/09/2012WO2012105873A1 Hydrated n-fullerene amino acids, method for producing the latter, and pharmaceutical compositions on the basis thereof
08/09/2012WO2012105872A1 Homo- and hetero-polyamino-acid derivatives of fullerene с60, method for producing same, and pharmaceutical compositions based on said derivatives
08/09/2012WO2012105798A2 Composition containing chlorogenic acid for preventing or treating gastroesophageal reflux disease
08/09/2012WO2012105767A2 Antiarrhythmic agent preparations having a ph-independent dissolution profile
08/09/2012WO2012105715A1 Novel external preparation
08/09/2012WO2012105708A1 Novel crystal of tetrahydronaphthalene compound
08/09/2012WO2012105707A1 Method of treating ischemia/reperfusion injury
08/09/2012WO2012105706A1 Keloid therapeutic agent
08/09/2012WO2012105674A1 Drug therapy for preventing or treating glaucoma
08/09/2012WO2012105635A1 2-oxy-substituted 8-oxodihydropurine derivative
08/09/2012WO2012105625A1 Transdermal absorption-promoting agent and transdermal patch containing same
08/09/2012WO2012105624A1 Transdermal patch
08/09/2012WO2012105623A1 Production method for adhesive patch
08/09/2012WO2012105622A1 Patch preparation
08/09/2012WO2012105621A1 Production method for adhesive patch
08/09/2012WO2012105618A1 Patch preparation
08/09/2012WO2012105610A1 Medicinal agent for prevention or treatment of diseases associated with intraocular neovascularization and/or intraocular vascular hyperpermeability
08/09/2012WO2012105594A1 Ring-fused heterocyclic derivative
08/09/2012WO2012105588A1 Tetrahydroisoquinoline derivative
08/09/2012WO2012105573A1 CYCLIC SULFONIUM SALT, PROCESS FOR PRODUCTION OF SAME, AND α-GLUCOSIDASE INHIBITOR COMPRISING SAME
08/09/2012WO2012105563A1 Veterinary drug comprising macrolide derivative
08/09/2012WO2012105562A1 Novel macrolide derivative
08/09/2012WO2012105546A1 Process for producing aqueous solution containing fat-soluble substance
08/09/2012WO2012105542A1 External preparation for skin
08/09/2012WO2012105521A1 Externally-used drug for treating skin disorder and method for producing same
08/09/2012WO2012105486A1 Tegafur-containing composition for single daily and alternate-day dosing
08/09/2012WO2012105477A1 Analgesic
08/09/2012WO2012105476A1 Prophylactic or therapeutic drug for peripheral neuropathy caused by anticancer agent
08/09/2012WO2012105475A1 Therapeutic or prophylactic agent for cachexia
08/09/2012WO2012105467A1 Oligonucleic acid composition and antiallergic agent
08/09/2012WO2012105312A1 Arthritis prevention/amelioration substance
08/09/2012WO2012105130A1 Fat and oil composition for promoting insulin secretion
08/09/2012WO2012104875A1 Benzothiazole hybrids useful as anticancer agents and process for the preparation thereof
08/09/2012WO2012104874A2 Aqueous concentrated formulation of linezolid
08/09/2012WO2012104869A1 Treatment for lipodystrophy
08/09/2012WO2012104857A1 Amidobenzothiazoles and process for the preparation thereof
08/09/2012WO2012104852A1 Dosage regimen, medication dispensing package and uses thereof for the treatment of major depressive disorder
08/09/2012WO2012104846A1 Ras inhibitors for treating diseases or pathological conditions characterized insulin resistance
08/09/2012WO2012104823A2 Pyridopyrimidinone compounds in the treatment of neurodegenerative diseases
08/09/2012WO2012104822A1 Combinations comprising macitentan for the treatment of glioblastoma multiforme
08/09/2012WO2012104818A1 Oral controlled release pharmaceutical compositions of bepotastine
1 ... 1089 1090 1091 1092 1093 1094 1095 1096 1097 1098 1099 1100 1101 1102 1103 1104 1105 1106 1107 1108 1109 ... 7860